Nanobodies—miniature proteins—derived from camel antibodies demonstrated powerful potential to accurately and safely deliver ...
A 4th dose of the bivalent or monovalent Omicron BA.1-adapted BNT162b2 vaccine elicits robust neutralizing responses in adults aged 18 to 55.
Mycobacterial diseases, including tuberculosis (TB), leprosy, and non-tuberculous mycobacterial (NTM) infections, continue to impose a substantial global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results